ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ROQ Roquefort Therapeutics Plc

4.35
0.15 (3.57%)
29 Nov 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 202120222023
GBP (£)GBP (£)GBP (£)
Total Revenue 1,0000200k
Operating Income -916k-1.63M-1.93M
Pre Tax Income -916k-1.63M-1.93M
Net Income -916k-1.62M-1.75M
Preferred Dividends 000
Basic Earnings Per Share (EPS) -1.3-1.3-1.4
EBIT -916k-1.63M-1.93M
EBITDA -916k-1.63M-1.93M

Your Recent History

Delayed Upgrade Clock